Sponsor pipeline

MediciNova clinical trial pipeline

2 active trials 0 recruiting 1 Phase 3 2 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 2		1
Phase 2/3		1

NCT ID	Title	Condition	Status	Updated
Phase 2/3
NCT04057898	Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6…	Amyotrophic Lateral Sclerosis	Active, Not Recruiting	2026-03-06
Phase 2
NCT05464784	MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and…	Diabetes Mellitus, Type 2	Active, Not Recruiting	2026-02-05

ALS (1) · Diabetes (1)

Get alerts when MediciNova's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.